Ra Pharmaceuticals, Inc.
(NASDAQ : RARX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc. -0.18%82.340.7%$1003.42m
ABBVAbbVie, Inc. 0.75%94.942.3%$973.87m
PFEPfizer Inc. -0.36%35.720.9%$961.68m
JNJJohnson & Johnson 1.09%149.980.7%$954.86m
BMYBristol-Myers Squibb Co. 0.71%65.631.0%$821.43m
LLYEli Lilly & Co. 0.01%142.021.1%$477.36m
NVSNovartis AG 0.51%96.780.2%$195.11m
GSKGlaxoSmithKline Plc 0.77%43.090.2%$170.89m
AZNAstraZeneca Plc 2.51%50.171.2%$154.28m
BHCBausch Health Cos., Inc. 0.36%26.510.0%$95.29m
RETAReata Pharmaceuticals, Inc. -5.64%211.143.5%$93.53m
SNYSanofi 0.20%50.850.2%$83.50m
NVONovo Nordisk A/S 0.55%63.860.1%$79.97m
GNPXGenprex, Inc. 21.69%5.330.0%$70.62m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -1.26%45.300.0%$55.97m

Company Profile

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of peptide-based drugs for a variety of therapeutic uses. The company's product include RA101495 SC, which is an injection into the tissue under the skin, for the treatment of paroxysmal nocturnal hemoglobinuria. Ra Pharmaceuticals was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.